Explore more publications!
Hawaii Tech Times
Got News to Share?

Hawaii Tech Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Hawaii Tech Times.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on February 23, 2026

Enitech Marks 13-Year Milestone, Reinforcing Role in Structured Cabling for Restaurants, Including 6 Michelin-Recommended Locations
Feb. 23, 2026

Enitech Marks 13-Year Milestone, Reinforcing Role in Structured Cabling for Restaurants, Including 6 Michelin-Recommended Locations

Indeterminate GlobeNewswire
Supernus Pharmaceuticals to Participate in March Investor Conferences
Feb. 23, 2026

Supernus Pharmaceuticals to Participate in March Investor Conferences

Indeterminate GlobeNewswire
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
Feb. 23, 2026

MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial

Indeterminate GlobeNewswire
BlackRock® Canada Announces Final February Cash Distributions for the iShares® Premium Money Market ETF
Feb. 23, 2026

BlackRock® Canada Announces Final February Cash Distributions for the iShares® Premium Money Market ETF

Indeterminate GlobeNewswire
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
Feb. 23, 2026

Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026

Indeterminate GlobeNewswire
Calian Appoints Will Majic as Acting Chief Financial Officer
Feb. 23, 2026

Calian Appoints Will Majic as Acting Chief Financial Officer

Indeterminate GlobeNewswire
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Feb. 23, 2026

Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Silo Pharma Announces Share Buyback Program
Feb. 23, 2026

Silo Pharma Announces Share Buyback Program

Indeterminate GlobeNewswire
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March
Feb. 23, 2026

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March

Indeterminate GlobeNewswire
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
Feb. 23, 2026

Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference

Indeterminate GlobeNewswire
Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution
Feb. 23, 2026

Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution

Indeterminate GlobeNewswire
EverQuote Announces Fourth Quarter and Full Year 2025 Financial Results
Feb. 23, 2026

EverQuote Announces Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire
Sana Biotechnology to Present at March 2026 Investor Conferences
Feb. 23, 2026

Sana Biotechnology to Present at March 2026 Investor Conferences

Indeterminate GlobeNewswire
ROC Announces Closing of Upsized Initial Public Offering
Feb. 23, 2026

ROC Announces Closing of Upsized Initial Public Offering

Indeterminate GlobeNewswire
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates
Feb. 23, 2026

ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates

Indeterminate GlobeNewswire
Tarsus Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Achievements
Feb. 23, 2026

Tarsus Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Achievements

Indeterminate GlobeNewswire
PROCEPT BioRobotics® Announces Updated Dates for 4Q25 Earnings Conference Call and Investor Day
Feb. 23, 2026

PROCEPT BioRobotics® Announces Updated Dates for 4Q25 Earnings Conference Call and Investor Day

Indeterminate GlobeNewswire
Galapagos Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
Feb. 23, 2026

Galapagos Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update

Indeterminate GlobeNewswire
Galapagos rapporteert resultaten over het gehele jaar 2025 en geeft een business update over het vierde kwartaal
Feb. 23, 2026

Galapagos rapporteert resultaten over het gehele jaar 2025 en geeft een business update over het vierde kwartaal

Indeterminate GlobeNewswire
Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board
Feb. 23, 2026

Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions